feedback

Course Directors

Hetty Carraway
Hetty Carraway, MD, MBA

Department of Hematologic Oncology and Blood Disorders
Taussig Cancer Institute
Cleveland Clinic
Cleveland, OH

Sudipto Mukherjee
Sudipto Mukherjee, MD, MPH

Cleveland Clinic
Cleveland, OH

Faculty

Corey Cutler, MD, MPH, FRCP(C)

Associate Professor of Medicine
Harvard Medical School
Senior Physician
Department of Medical Oncology
Dana-Farber Cancer Institute
Boston, MA

Guillermo Garcia-Manero
Guillermo Garcia-Manero, MD

Professor of Medicine
Chief, Section of MDS
Department of Leukemia
MD Anderson Cancer Center
University of Texas
Houston, TX

Disclosure: No relevant financial relationships to disclose.

Mark Levis, MD, PhD

Director, Adult Leukemia Service
Co-Director, Division of Hematologic Malignancies
Professor of Oncology, Medicine, and Pharmacology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Johns Hopkins University School of Medicine
Baltimore, MD

Laura C. Michaelis, MD

Associate Professor of Medicine
Associate Vice Chair Division of Hematology and Oncology
Medical College of Wisconsin
Milwaukee, WI

Valeria Santini, MD

University of Florence
Florence, Italy

Gerard Socie

Hopital St. Louis
Paris, France

Accredited by

Cleveland Clinic Center for Continuing Education

View Activity Materials

Course Description

Learning Objectives
1. Define the clinical implications of aberrant somatic and germline mutations in normal bone marrow, ICUS (idiopathic cytopenia of undetermined significance), CHIP (clonal hematopoiesis of indeterminate potential), myelodysplastic syndromes (MDS), and other myeloid neoplasms.
2. Describe the genomic mutations in MPNs and their impact on pathogenesis and treatment options.
3. Identify the role of targeted therapies in myeloid malignancies.
4. Describe the impact of checkpoint inhibitors for the treatment of MDS/AML.
5. Describe the treatment options for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PNH).
6. Identify the risks and benefits of bone marrow transplant in therapy-related myeloid malignancies.

Activity Details

Credit Types:CME
Credit Amount:3.50 Credits
Release Date:2018-Jan-08
Expiration Date:2020-Jan-08
Estimated Time for Completion:3.5 hours
Registration Required:Yes
Cost:Free

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.